June 16, 2020 / 12:24 PM / 23 days ago

BRIEF-Biomerica Files For FDA Emergency Use Authorization Of Unique Laboratory Antibody Test For Covid-19

June 16 (Reuters) - Biomerica Inc:

* BIOMERICA FILES FOR FDA EMERGENCY USE AUTHORIZATION (EUA) OF ITS UNIQUE LABORATORY ANTIBODY TEST FOR COVID-19

* BIOMERICA INC - FILED A PROVISIONAL PATENT ON TECHNOLOGY TO ALLOW SIMPLIFIED BLOOD COLLECTION

* BIOMERICA INC - ELISA LABORATORY TEST WILL BE MANUFACTURED EXCLUSIVELY AT BIOMERICA’S MANUFACTURING FACILITY LOCATED IN CALIFORNIA

* BIOMERICA INC - ALSO INTENDS TO OBTAIN A CE MARK TO MARKET AND SELL ELISA LABORATORY TEST OUTSIDE U.S. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below